In a newly-released case study, Medpace #neuropsychiatry experts discuss the challenges and strategies of a Phase II major depressive disorder (#MDD) trial, including overcoming concerns about potential misuse of the study drug, mitigating the impact of placebo response, reducing patient burden, and more. Download the MDD #CaseStudy to explore successful approaches to streamlining psychiatry clinical development: https://lnkd.in/gGKZPb4t
Good point!
Chief Executive Officer at USA and International Research Inc.
1dGreat insights from Medpace’s neuropsychiatry experts! The case study on Phase II MDD trials sounds incredibly valuable for addressing key challenges. #MDD #ClinicalDevelopment